Clinical trial
A Phase II Study of Letrozole in Patients With Advanced or Recurrent Endometrial Cancer
NCT00004251 is registered in ClinicalTrials.gov with NCIC Clinical Trials Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Letrozole in Patients With Advanced or Recurrent Endometrial Cancer
- Lead sponsor
- NCIC Clinical Trials Group
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 19, 2000
- Completion date
- January 18, 2011
- Enrollment
- 33 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial cancer